VXL.V

Vaxil Bio Ltd. [VXL.V] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VXL.V Stock Summary

In the News

VXL.V Financial details

Company Rating
Neutral
Market Cap
1.37M
Income
-453K
Revenue
0
Book val./share
0.01
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-7.56
Forward P/E
-
PEG
1.4
P/S
-
P/B
3.98
P/C
1.5
P/FCF
-6.76
Quick Ratio
5.53
Current Ratio
5.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-40.28%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-77.78%
-
-
-
-
SMA20
-66.67%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-43%
ROE
-47%
ROC
-0.53%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
136.98M
Shs Float
125.79M
-
-
-
-
Target Price
-
52W Range
0.01-0.035
52W High
-
52W Low
-
RSI
46.57
Rel Volume
4.22
Avg Volume
75.6K
Volume
319K
Perf Week
50%
Perf Month
-40%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-3.527
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.015
Change
0%

VXL.V Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.01-0.01-0.010
Operating cash flow per share
-0.01-0.01-0.01-0.01-0.01
Free cash flow per share
-0.01-0.01-0.01-0.01-0.01
Cash per share
0.0100.010.020.01
Book value per share
0.01-0.010.010.010.01
Tangible book value per share
0.01-0.010.010.010.01
Share holders equity per share
0.01-0.010.010.010.01
Interest debt per share
00000
Market cap
2.55M3.11M30.52M10.21M2.74M
Enterprise value
1.81M3.05M29.02M7.97M1.23M
P/E ratio
-2.44-2.67-22.29-10.35-4.69
Price to sales ratio
00000
POCF ratio
-2.71-5.22-27.67-9.42-3.73
PFCF ratio
-2.71-5.22-27.67-9.42-3.73
P/B Ratio
5.87-5.3437.9662.41
PTB ratio
5.87-5.3437.9662.41
EV to sales
00000
Enterprise value over EBITDA
-1.83-2.92-22.5-8.29-2.11
EV to operating cash flow
-1.92-5.11-26.31-7.35-1.68
EV to free cash flow
-1.92-5.11-26.31-7.35-1.68
Earnings yield
-0.41-0.37-0.04-0.1-0.21
Free cash flow yield
-0.37-0.19-0.04-0.11-0.27
Debt to equity
0.01-0.030.0100
Debt to assets
0.010.080.0100
Net debt to EBITDA
0.760.061.162.332.59
Current ratio
1.820.141.913.93.8
Interest coverage
0-103.91-122.4500
Income quality
0.90.520.811.11.26
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.040.040.050.050.03
ROIC
-2.352.1-1.65-0.58-0.51
Return on tangible assets
-1.18-5.68-0.82-0.43-0.38
Graham Net
0-0.010.010.010.01
Working capital
373K-667K777K1.7M1.14M
Tangible asset value
435K-583K804K1.7M1.14M
Net current asset value
373K-678K777K1.7M1.14M
Invested capital
0.01-0.030.0100
Average receivables
35K34K22K34K27.5K
Average payables
386.5K476.5K603K294.28K476.5
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
02.26K3.77K8.1671.91
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00.160.144.725.08
Inventory turnover
00000
ROE
-2.412-1.7-0.58-0.51
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
0.010.010.010.010.01
Book value per share
0.010.010.010.010.01
Tangible book value per share
0.010.010.010.010.01
Share holders equity per share
0.010.010.010.010.01
Interest debt per share
00000
Market cap
4.11M2.74M2.74M2.74M2.05M
Enterprise value
2.42M1.23M1.4M1.68M1.05M
P/E ratio
-7.39-3.96-5.48-5.39-18.35
Price to sales ratio
00000
POCF ratio
-26.34-14.97-16.7-9.82-41.93
PFCF ratio
-26.34-14.97-16.7-9.82-41.93
P/B Ratio
3.162.412.713.092.39
PTB ratio
3.162.412.713.092.39
EV to sales
00000
Enterprise value over EBITDA
-17.44-7.11-11.18-13.19-27.52
EV to operating cash flow
-15.54-6.72-8.52-6.01-21.34
EV to free cash flow
-15.54-6.72-8.52-6.01-21.34
Earnings yield
-0.03-0.06-0.05-0.05-0.01
Free cash flow yield
-0.04-0.07-0.06-0.1-0.02
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
12.128.7310.748.3826.55
Current ratio
4.123.83.864.795.53
Interest coverage
00000
Income quality
1.121.061.312.21.75
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.010.020.010.010.01
ROIC
-0.11-0.15-0.12-0.14-0.04
Return on tangible assets
-0.08-0.11-0.09-0.11-0.03
Graham Net
0.010.010.010.010.01
Working capital
1.3M1.14M1.01M887K860K
Tangible asset value
1.3M1.14M1.01M887K860K
Net current asset value
1.3M1.14M1.01M887K860K
Invested capital
00000
Average receivables
39K27K20.5K39K49K
Average payables
208.5405.5373.5293.5212
Average inventory
-17K-17K-10.5K-39K-49K
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.11-0.15-0.12-0.14-0.03
Capex per share
00000

VXL.V Frequently Asked Questions

What is Vaxil Bio Ltd. stock symbol ?

Vaxil Bio Ltd. is a CA stock , located in Toronto of On and trading under the symbol VXL.V

What is Vaxil Bio Ltd. stock quote today ?

Vaxil Bio Ltd. stock price is $0.015 today.

Is Vaxil Bio Ltd. stock public?

Yes, Vaxil Bio Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range
Similar Market Cap